ANVS Annovis Bio Inc

Price (delayed)

$1.79

Market cap

$62.02M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.71

Enterprise value

$47.8M

?
Relative Growth: Rel. Growth: 5
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

Headquartered in Malvern, Pennsylvania, Annovis Bio Inc. is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore ...

Highlights
The EPS has declined by 22% since the previous quarter but it has grown by 19% year-on-year
The quick ratio has dropped by 88% year-on-year and by 79% since the previous quarter
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

Key stats

What are the main financial stats of ANVS

ANVS stock price

How has the Annovis Bio stock price performed over time
Intraday
-0.56%
1 week
-3.76%
1 month
1.7%
1 year
-33.7%
YTD
-48.27%
QTD
-3.76%

Financial performance

How have Annovis Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$41.42M
Net income
-$40.92M
Gross margin
N/A
Net margin
N/A
The company's operating income has shrunk by 65% YoY and by 39% QoQ
The net income is down by 42% since the previous quarter and by 41% year-on-year

Price vs fundamentals

How does ANVS's price correlate with its fundamentals

Growth

What is Annovis Bio's growth rate over time

Valuation

What is Annovis Bio stock price valuation
P/E
N/A
P/B
16.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 22% since the previous quarter but it has grown by 19% year-on-year
The price to book (P/B) is 158% more than the 5-year quarterly average of 6.3 and 108% more than the last 4 quarters average of 7.8
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

Efficiency

How efficient is Annovis Bio business performance
The company's return on equity has shrunk by 100% QoQ and by 6% YoY
The return on assets has dropped by 61% since the previous quarter and by 11% year-on-year

Dividends

What is ANVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANVS.

Financial health

How did Annovis Bio financials performed over time
Annovis Bio's total assets is 24% higher than its total liabilities
ANVS's current ratio has plunged by 88% YoY and by 78% from the previous quarter
The quick ratio has dropped by 88% year-on-year and by 79% since the previous quarter
The company's debt is 100% lower than its equity
ANVS's equity has dropped by 87% year-on-year and by 81% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.